Single Channel Properties and Structure of Glutamate Receptors

谷氨酸受体的单通道特性和结构

基本信息

  • 批准号:
    8440994
  • 负责人:
  • 金额:
    $ 41.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-01 至 2013-07-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glutamate-receptor ion channels (iGluRs) mediate the vast majority of excitatory synaptic transmission in the mammalian central nervous system. A host of studies have shown that the biophysical and kinetic properties of iGluRs play a key role in determining the amplitude and time-course of postsynaptic currents, as well as postsynaptic responses to repetitive presynaptic stimulation. The biophysical and kinetic properties of iGluRs are best revealed in studies of single receptor molecules, something that is possible with single-channel patch-clamp recording. In addition to the core subunits required to form functional receptors, in the last ten years it has become clear that iGluRs also contain auxiliary subunits. For the AMPA subtype of iGluRs, one family of such auxiliary subunits is the Transmembrane AMPA-receptor Regulatory Proteins (TARPs). In addition to playing a key role in AMPA receptor trafficking, our lab and others have demonstrated that TARPs modulate several features of AMPA receptor gating kinetics. Single-channel work that we have done strongly suggests that TARPs promote modal gating, where the receptors switch (on a time-scale of hundreds of milliseconds) between low and high Popen behavior. In Aim 1, we propose to further explore these initial findings and determine whether the effects differ for different TARPs. If the data support evidence of modal gating, we will test whether this behavior influences the character of synaptic responses to repetitive stimuli. We will also investigate the effect of agonist-induced uncoupling of TARP-receptor interactions on single-channel currents by comparing results from co-expression studies with those from experiments with tandem constructs where individual TARPs are fused directly to the receptors. In the prior funding period, we demonstrated that the kainate subtype of iGluRs also have auxiliary subunits (NETO1, NETO2) that modulate receptor kinetics. Again, our preliminary single-channel studies suggest that NETO2 strongly promotes modal gating of kainate receptors, an effect that has a dramatic impact on the shape and amplitude of receptor responses. We will extend these studies in Aim 2 of this proposal. We also have preliminary data showing that GluK1 receptors open hundreds of milliseconds after brief pulses of saturating concentrations of glutamate. These results suggest that kainate receptors recover from desensitization with glutamate still bound and that the rate-determining step in recovery is the rate at which the receptor re-sensitizes, rather than the rate at which glutamate dissociates from the desensitized receptor. In Aim 2 we will extend and quantify these preliminary studies.
描述(由申请人提供):谷氨酸受体离子通道(iGluRs)介导哺乳动物中枢神经系统中绝大多数兴奋性突触传递。大量研究表明,iGluRs的生物物理和动力学性质在决定突触后电流的幅度和时程以及对重复突触前刺激的突触后反应中起关键作用。iGluRs的生物物理和动力学特性在单受体分子的研究中得到了最好的揭示,单通道膜片钳记录是可能的。除了形成功能性受体所需的核心亚基之外,在过去的十年中,iGluRs还含有辅助亚基已经变得很清楚。对于iGluR的AMPA亚型,此类辅助亚基的一个家族是跨膜AMPA受体调节蛋白(TARP)。除了在AMPA受体运输中发挥关键作用外,我们的实验室和其他实验室已经证明,TARPs调节AMPA受体门控动力学的几个特征。我们所做的单通道工作强烈表明,TARP促进了模式门控,其中受体在低和高Popen行为之间切换(在数百毫秒的时间尺度上)。在目标1中,我们建议进一步探索这些初步发现,并确定不同的TARPs的影响是否不同。如果数据支持模态门控的证据,我们将测试这种行为是否会影响突触对重复刺激的反应。我们还将研究激动剂诱导的解偶联的TARP-受体相互作用对单通道电流的影响,通过比较来自共表达研究的结果与来自串联结构实验的结果,其中单个TARP直接融合到受体。在之前的资助期间,我们证明了iGluRs的红藻氨酸亚型也具有调节受体动力学的辅助亚基(NETO 1,NETO 2)。同样,我们的初步单通道研究表明,NETO 2强烈促进红藻氨酸受体的模式门控,这种效应对受体反应的形状和幅度产生巨大影响。我们将在本提案的目标2中扩展这些研究。我们也有初步的数据显示,GluK 1受体在谷氨酸饱和浓度的短暂脉冲后数百毫秒开放。这些结果表明,红藻氨酸受体从脱敏中恢复,谷氨酸仍然结合,并且恢复中的速率决定步骤是受体重新敏化的速率,而不是谷氨酸从脱敏受体解离的速率。在目标2中,我们将扩展和量化这些初步研究。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES R HOWE其他文献

JAMES R HOWE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES R HOWE', 18)}}的其他基金

Project 3: A Genomic Approach to Improved Diagnosis and Treatment of Neuroendocrine Tumors
项目 3:改进神经内分泌肿瘤诊断和治疗的基因组方法
  • 批准号:
    8850627
  • 财政年份:
    2015
  • 资助金额:
    $ 41.48万
  • 项目类别:
Project 3: A Genomic Approach to Improved Diagnosis and Treatment of Neuroendocrine Tumors
项目 3:改进神经内分泌肿瘤诊断和治疗的基因组方法
  • 批准号:
    10264530
  • 财政年份:
    2015
  • 资助金额:
    $ 41.48万
  • 项目类别:
Career Development Program
职业发展计划
  • 批准号:
    10264533
  • 财政年份:
    2015
  • 资助金额:
    $ 41.48万
  • 项目类别:
Regulation of SMAD4 and BMPR1A Expression in Juvenile Polyposis
SMAD4 和 BMPR1A 在幼年性息肉病中表达的调控
  • 批准号:
    7568021
  • 财政年份:
    2009
  • 资助金额:
    $ 41.48万
  • 项目类别:
Single Channel Properties and Structure of Glutamate Receptors
谷氨酸受体的单通道特性和结构
  • 批准号:
    7737350
  • 财政年份:
    2007
  • 资助金额:
    $ 41.48万
  • 项目类别:
Single Channel Properties and Structure of Glutamate Receptors
谷氨酸受体的单通道特性和结构
  • 批准号:
    7342787
  • 财政年份:
    2007
  • 资助金额:
    $ 41.48万
  • 项目类别:
Single Channel Properties and Structure of Glutamate Receptors
谷氨酸受体的单通道特性和结构
  • 批准号:
    7192052
  • 财政年份:
    2007
  • 资助金额:
    $ 41.48万
  • 项目类别:
Single Channel Properties and Structure of Glutamate Receptors
谷氨酸受体的单通道特性和结构
  • 批准号:
    7869478
  • 财政年份:
    2007
  • 资助金额:
    $ 41.48万
  • 项目类别:
Single Channel Properties and Structure of Glutamate Receptors
谷氨酸受体的单通道特性和结构
  • 批准号:
    7536090
  • 财政年份:
    2007
  • 资助金额:
    $ 41.48万
  • 项目类别:
Recovery from AMPA Receptor Desensitization
AMPA 受体脱敏恢复
  • 批准号:
    6984761
  • 财政年份:
    2003
  • 资助金额:
    $ 41.48万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 41.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 41.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 41.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了